BBR Partners »

Aclaris Therapeutics shares owned by BBR Partners

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by BBR Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $66k 60k 1.10
2024-03-31 $74k 60k 1.24

More positions owned by BBR Partners

Spdr S&p 500 Etf (SPY)
iShares S&P 500 Index (IVV)
United Parcel Service (UPS)
Apple (AAPL)
Vanguard S&p 500 Etf idx (VOO)
Microsoft Corporation (MSFT)
Kkr & Co (KKR)
Vanguard Total Stock Market ETF (VTI)
Invesco S&p 500 Equal Weight Etf (RSP)
Vanguard Information Technology ETF (VGT)
Alphabet Inc Class A cs (GOOGL)
Philip Morris International (PM)
Abbvie (ABBV)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway (BRK.B)

View all positions for BBR Partners

Top funds holding Aclaris Therapeutics

BML Capital Management
Vanguard Group
Millennium Management
D. E. Shaw & Co
Rock Springs Capital Management
BlackRock
Stonepine Capital Management
Acadian Asset Management
Trium Capital
Two Sigma Advisers
Two Sigma Investments
Bain Capital Life Sciences Investors
Qube Research & Technologies
Deutsche Bank Aktiengesellschaft
Renaissance Technologies

View all funds holding Aclaris Therapeutics